The board of directors of Everest Medicines Limited announced that Ms. Yin Yin (Ms. Yin) has tendered her resignation as a joint company secretary of the company with effect from January 31, 2022 due to personal reason.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.95 HKD | +1.86% | -3.30% | +5.02% |
14/05 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
14/05 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.02% | 88Cr | |
-1.62% | 9.09TCr | |
-1.05% | 3.9TCr | |
-10.77% | 3.35TCr | |
-19.68% | 1.45TCr | |
-5.89% | 1.32TCr | |
-11.42% | 1.17TCr | |
-47.31% | 1.06TCr | |
+6.52% | 923.36Cr | |
+102.03% | 770.73Cr |
- Stock Market
- Equities
- 1952 Stock
- News Everest Medicines Limited
- Everest Medicines Limited Announces Resignation of Ms. Yin Yin as Joint Company Secretary